Dr Reddy's Laboratories

RDY · NATIONAL

$13.21−$0.02 (−0.15%)TodayMarket closed ·
Prev close $13.23

About RDY

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Employees
27,527
Headquarters
Hyderabad, Telangana
Listed
Jan 1, 1986
Sector
Health Care
Industry
Pharmaceuticals

Leadership

Dr Reddy's Laboratories executives
NameTitleSince
Kallam Reddy—2022
Gunupati Prasad—2001
Erez Israeli——
Mannam Narasimham—2024
Patrick Aghanian——
M. Ramana——
Deepak Sapra——
Phanimitra B——
K. Singh——
Sushrut Kulkarni——
Sanjay Sharma——
Leo Puri——
Claudio Albrecht——
Kodumudi Krishnan——
Arun Kumar——
Sanjiv Mehta——
Alpna Seth——
Shikha Sharma——
Chan Wan——
Richa Periwal—2025

Revenue by product and region

Fiscal year ended Mar 31, 2026: $3.58B total revenue

By product

  • Global Generics [Member]$299.03B8352.9%
  • Pharmaceutical Services and Active Ingredients [Member]$34.77B971.3%
  • Other segment [Member]$2.13B59.4%

By region

  • Others Countries Country [Member]$118.72B3316.1%
  • UNITED STATES$117.89B3293.1%
  • India Country [Member]$64.54B1802.7%
  • Russia Country [Member]$34.79B971.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.